相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial
Ahmet Sezer et al.
LANCET (2021)
Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study
R. Dummer et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial
Michael R. Migden et al.
LANCET ONCOLOGY (2020)
Neoadjuvant checkpoint blockade for cancer immunotherapy
Suzanne L. Topalian et al.
SCIENCE (2020)
Immune checkpoint inhibitors to treat cutaneous malignancies
Dulce M. Barrios et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing
Danny Rischin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
Aurelien Marabelle et al.
LANCET ONCOLOGY (2020)
Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study
Anne Lynn S. Chang et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Implementing TMB measurement in clinical practice: considerations on assay requirements
Reinhard Buettner et al.
ESMO OPEN (2019)
Emerging trends in the treatment of advanced basal cell carcinoma
Michael R. Migden et al.
CANCER TREATMENT REVIEWS (2018)
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
M. R. Migden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Update on Keratinocyte Carcinomas
Kishwer S. Nehal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial
N. Basset-Seguin et al.
EUROPEAN JOURNAL OF CANCER (2017)
Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial
Brigitte Dreno et al.
LANCET ONCOLOGY (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study
Aleksandar Sekulic et al.
BMC CANCER (2017)
Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810
Gerald S. Falchook et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Management of high-risk and advanced basal cell carcinoma
S. Puig et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2015)
Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC
Aleksandar Sekulic et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial
Michael R. Migden et al.
LANCET ONCOLOGY (2015)
Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes
Lynn E. Macdonald et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice
Andrew J. Murphy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Basal-Cell Carcinoma Incidence and Associated Risk Factors in US Women and Men
Shaowei Wu et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Hedgehog Signaling Controls T Cell Killing at the Immunological Synapse
Maike de la Roche et al.
SCIENCE (2013)
Initial Assessment of Tumor Regrowth After Vismodegib in Advanced Basal Cell Carcinoma
Anne Lynn S. Chang et al.
ARCHIVES OF DERMATOLOGY (2012)
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
Aleksandar Sekulic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Cancer-Testis Antigens and Immunosurveillance in Human Cutaneous Squamous Cell and Basal Cell Carcinomas
Anne Walter et al.
CLINICAL CANCER RESEARCH (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Medical progress - Skin cancers after organ transplantation
S Euvrard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
